Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Medicare, CMS, calls for cancelling or postponing all elective or non-essential medical procedures, test and surgeries due to COVID-19. #COVID19 #SARcov2 #coronavirus #cardiology

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

CMS Calls For Postponing All Elective Cardiac Tests and Procedures to Aid COVID-19 Containment

March 20, 2020 — The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective ...

March 20, 2020

Videos | Coronavirus (COVID-19)

VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak

An interview with Ehtisham Mahmud, M.D., FSCAI, chief, Division of Cardiovascular Medicine, executive director of ...

March 20, 2020

News | Artificial Heart

FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant

March 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total ...

March 10, 2020

ACC issues document outlining COVID-19 Implications For Patients With Underlying Cardiovascular Conditions. The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate. #COVID19 #coronavirus #2019nCoV #SARS‐CoV‐2

Feature | Coronavirus (COVID-19)

ACC COVID-19 Clinical Guidance For the Cardiovascular Care Team

March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel coronavirus ...

March 09, 2020

News | Heart Failure

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation

March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA ...

March 05, 2020

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

News | Cardiovascular Surgery

How to Reduce the Risk of Cardiac Surgery Infection When Using LivaNova Heater-Cooler System

February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to ...

February 27, 2020

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI

Feature | Heart Valve Technology | Dave Fornell, Editor

TAVR Expected to See Rapid Growth in Next 5 years

In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter aortic ...

February 24, 2020

he U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S. early feasibility study (EFS) of its total artificial heart.

News | Heart Failure

Carmat to initiate FDA U.S. Feasibility Study of Total Artificial Heart

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption ...

February 12, 2020

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive heart valve replacement to open-heart surgery. Photo by Cedars-Sinai. TAVR performs as well as surgery for aortic valve replacement.

News | Heart Valve Technology

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that ...

January 31, 2020

Mayo Clinic uses the Da Vinci surgical robot to perform minimally invasive mitral valve surgeries.

News | Robotic Systems

Robotic Mitral Valve Repair May Offer Benefit for Many Patients

January 20, 2020 — Research has found that repairing the mitral valve earlier, before the mitral valve prolapse ...

January 20, 2020

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.

News | Cardiac Rehabilitation

Only 1 in 4 Medicare Patients Participate in Cardiac Rehabilitation

January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart ...

January 15, 2020

Videos | Cath Lab

VIDEO: The Role of Intensivists on the Cardiac Critical Care Team

Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant ...

January 09, 2020

Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery. The new, less invasive approach is designed to provide surgeons a choice in surgical method for patients receiving the HeartMate 3 Left Ventricular Assist Device (LVAD).

News | Ventricular Assist Devices (VAD)

FDA Approves Less Invasive Surgical Approach for HeartMate 3 Heart Pump

January 7, 2020 — Abbott announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical ...

January 07, 2020

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

News | Cath Lab | Dave Fornell, Editor

EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdre ...

January 02, 2020

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

News | Heart Valve Technology

Tissue Engineering Will Disrupt Cardiovascular Implant Market

While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and ...

December 26, 2019